Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,616 INR | +1.35% | +4.42% | +22.15% |
Apr. 24 | Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility | MT |
Apr. 22 | INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains | RE |
Sales 2024 * | 199B 2.39B | Sales 2025 * | 217B 2.61B | Capitalization | 727B 8.73B |
---|---|---|---|---|---|
Net income 2024 * | 19.88B 239M | Net income 2025 * | 23.39B 281M | EV / Sales 2024 * | 3.78 x |
Net Debt 2024 * | 24.53B 295M | Net Debt 2025 * | 8.87B 107M | EV / Sales 2025 * | 3.38 x |
P/E ratio 2024 * |
36.7
x | P/E ratio 2025 * |
31.4
x | Employees | 20,933 |
Yield 2024 * |
0.45% | Yield 2025 * |
0.53% | Free-Float | 52.83% |
Latest transcript on Lupin Limited
1 day | +1.37% | ||
1 week | +4.44% | ||
Current month | -0.04% | ||
1 month | +0.08% | ||
3 months | +8.96% | ||
6 months | +41.57% | ||
Current year | +22.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 96-12-31 | |
Johnny Mikell
PSD | President | - | - |
Director of Finance/CFO | 59 | 07-08-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 15-10-26 | |
Mark McDade
BRD | Director/Board Member | 69 | 21-01-27 |
Director/Board Member | 50 | 95-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1,616 | +1.35% | 587 175 |
24-04-25 | 1,594 | +0.91% | 1,203,147 |
24-04-24 | 1,580 | -0.00% | 1,363,206 |
24-04-23 | 1,580 | -1.47% | 849,166 |
24-04-22 | 1,604 | +3.63% | 1,301,274 |
Delayed Quote NSE India S.E., April 26, 2024 at 04:23 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.75% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.19% | 233B | |
+5.23% | 201B | |
-10.06% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- LUPIN Stock
- LUPIN Stock